Amphastar Pharmaceuticals Statistics and Revenue Totals (2023)
Last Updated on: January 8th, 2023
Here are a few of the most interesting Amphastar Pharmaceuticals statistics I was able to dig up including Amphastar Pharmaceuticals revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Amphastar Pharmaceuticals Facts
- Website: Official Website
- Year Founded: 2004
- Headquarters: Rancho Cucamonga, CA
- Current Chief Executive: Jack Yongfeng Zhang
Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center. Amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. We currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. Amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the U.S. enables it to establish significant market share upon the introduction of its new products. (source)
Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center. Amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. We currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. Amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the U.S. enables it to establish significant market share upon the introduction of its new products. (Amphastar Pharmaceuticals Statistics
Amphastar Pharmaceuticals Employee Count
Number of Amphastar Pharmaceuticals employees:
Last updated 1/1/20
Amphastar Pharmaceuticals Revenue Totals
Amphastar Pharmaceuticals annual revenue:
- 2021: $437 million
- 2020: $349 million
- 2019: $322 million
- 2018: $294 million
- 2017: $240 million
- 2016: $255 million
- 2015: $251 million
Amphastar Pharmaceuticals annual net income:
- 2021: $63.5 million
- 2020: $1.1 million
- 2019: $46.5 million
- 2018: $6.6 million net loss
- 2017: $3.6 million
- 2016: $9.8 million
- 2015: $2.6 million net loss
Please note that some of these numbers are easier to find than others. A few of these Amphastar Pharmaceuticals statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags: